Gadolinium News and Research

RSS

Initial Phase II study results of ofatumumab in patients with RRMS announced

Genmab A/S announced today positive interim results from an ofatumumab Phase II safety and pharmacokinetics study in patients with relapsing-remitting multiple sclerosis.

7 Jul 2010

CMMC installs Toshiba's Vantage Titan MR system to accommodate bariatric patients

Obesity is a growing trend in the United States, requiring hospitals to provide medical imaging technology designed to accommodate bariatric patients without compromising diagnostic confidence or patient comfort. To accomplish this goal, Central Mississippi Medical Center in Jackson, Miss., a bariatric center of excellence, recently installed Toshiba America Medical Systems, Inc.'s Vantage Titan MR system.

28 Jun 2010

Research findings offer possible applications in diagnosis and treatment of patients with atherosclerosis

Researchers from Boston University School of Medicine have shown that use of magnetic resonance imaging in an animal model can non-invasively identify dangerous plaques. The findings, which appear in the May issue of Circulation Cardiovascular Imaging, offer possible applications in the diagnosis and treatment of patients with atherosclerosis.

26 May 2010

Mayo Clinic study finds changes in tissue damage throughout the course of MS

A new Mayo Clinic study has found that the type of tissue damage changes throughout the course of multiple sclerosis. In early relapsing disease stages, the plaques, or areas where the nervous system is inflamed or demyelinated, are predominantly active with distinct heterogeneous patterns of myelin damage.

23 Apr 2010

Epix Pharmaceuticals' MRI imaging intellectual properties to be auctioned on May 28, 2010

Joseph F. Finn, Jr., C.P.A., Assignee for the Benefit of Creditors of Epix Pharmaceuticals, Inc., announced today that the MRI imaging intellectual properties will be auctioned on May 28, 2010. The assets of Epix were transferred to him on July 20, 2009 and he is liquidating them for the benefit of Epix creditors. He recently reached an agreement with Bayer Schering Pharma that permits the sale of the MRI imaging programs.

19 Apr 2010

Epix Pharmaceuticals' MRI imaging intellectual properties to be auctioned on May 28, 2010

Joseph F. Finn, Jr., C.P.A., Assignee for the Benefit of Creditors of Epix Pharmaceuticals, Inc. ("Epix"), announced today that the MRI imaging intellectual properties will be auctioned on May 28, 2010. The assets of Epix were transferred to him on July 20, 2009 and he is liquidating them for the benefit of Epix creditors. He recently reached an agreement with Bayer Schering Pharma that permits the sale of the MRI imaging programs.

12 Apr 2010

Little Company of Mary installs Toshiba America Medical Systems' Vantage Atlas MR system

In response to concern over gadolinium-based contrast agents, Little Company of Mary, a not-for-profit Catholic community hospital in Evergreen Park, Ill., wanted to provide the highest quality and safest MRA procedures to its patients. To accomplish this, the facility installed Toshiba America Medical Systems, Inc.’s Vantage Atlas® MR system and utilized the full suite of proprietary contrast-free MRA techniques.

25 Feb 2010

Combination of daclizumab and interferon beta significantly reduces MS lesion formation

Biogen Idec and Facet Biotech Corporation today announced the publication of Phase 2 data showing that the addition of daclizumab to interferon beta (IFNβ) led to a significant reduction in the number of new or enlarged multiple sclerosis (MS) lesions when compared to IFNβ alone in patients with active relapsing forms of MS.

17 Feb 2010

Second-quarter fiscal 2010 results announced by Pharmacyclics

Pharmacyclics, Inc. today reported financial results for its second fiscal quarter ended December 31, 2009.

12 Feb 2010

Acute adverse reactions rare from using gadolinium-based contrast agents during MRI

Acute adverse reactions from gadolinium-based contrast agents used during magnetic resonance imaging (MRI) to help improve the information seen on the images rarely occur, according to a study published in the February issue of the American Journal of Roentgenology.

22 Jan 2010

Dramatically enhanced image contrast could revolutionize diagnostics and therapeutics

A Northwestern University study shows that coupling a magnetic resonance imaging (MRI) contrast agent to a nanodiamond results in dramatically enhanced signal intensity and thus vivid image contrast.

18 Jan 2010

NIH $1 million Challenge Grant to refine cell-tracking nanotube technology

The National Institutes of Health (NIH) has awarded researchers at Rice University and the Texas Heart® Institute (THI) a $1 million Challenge Grant to refine cell-tracking nanotube technology that could make magnetic resonance imaging (MRI) up to 40 times more sensitive than existing MRIs and help guide adult stem cells within the human body to repair damaged hearts.

10 Nov 2009

Covidien contraindicates use of its Optimark gadoversetamide injection

Covidien, a leading global provider of healthcare products, today announced that it will voluntarily contraindicate the use of its Optimark™ gadoversetamide injection, a gadolinium-based contrast agent (GBCA), in magnetic resonance imaging (MRI) procedures involving patients with severe renal impairment.

9 Nov 2009

Discovery of AVM can relieve pain due to chronic back pain and neurologic deficits

The discovery of a multi-level arteriovenous malformation (AVM) in the thoracic epidural space can now bring relief to potentially thousands of suffers of chronic thoracic pain and progressive myelopothy. Identified as thoracic epidural arteriovenous malformation (T.E.A.M.), this particular AMV primarily affects younger women ages 20 to 40.

27 Oct 2009

St. Anthony Hospital installs Toshiba America Medical Systems' Vantage Titan MR system

To provide the latest in MR technology to its patient community, St. Anthony Hospital in Gig Harbor, Wash. installed the Vantage TitanTM from Toshiba America Medical Systems, Inc. to offer comprehensive MR patient exams. The new 80-bed St. Anthony hospital is the only full service facility in the area and needed a workhorse MR system to conduct a full range of exams.

18 Oct 2009

Iodinated, Gadolinium based contrast agents do not negatively affect patients

Iodinated and Gadolinium based contrast agents, frequently used during computed tomography (CT) and MRI scans to aid in the imaging process, are associated with a very low rate of adverse effects, according to a large cohort study published in the October issue of the American Journal of Roentgenology (AJR).

21 Sep 2009

Toshiba America Medical Systems installs its 800th Vantage 1.5T MR system

Toshiba America Medical Systems, Inc., an industry leader in magnetic resonance (MR) technology, reached a significant achievement in installing its 800th Vantage 1.5T MR system at Elkview General Hospital in Hobart, Okla. Elkview is using the Vantage system for orthopedic, neuro and abdominal imaging.

25 Aug 2009

Gadolinium News and Research

Initial Phase II study results of ofatumumab in patients with RRMS announced

CMMC installs Toshiba's Vantage Titan MR system to accommodate bariatric patients

Research findings offer possible applications in diagnosis and treatment of patients with atherosclerosis

Mayo Clinic study finds changes in tissue damage throughout the course of MS

Epix Pharmaceuticals' MRI imaging intellectual properties to be auctioned on May 28, 2010

Epix Pharmaceuticals' MRI imaging intellectual properties to be auctioned on May 28, 2010

Little Company of Mary installs Toshiba America Medical Systems' Vantage Atlas MR system

Combination of daclizumab and interferon beta significantly reduces MS lesion formation

Second-quarter fiscal 2010 results announced by Pharmacyclics

Acute adverse reactions rare from using gadolinium-based contrast agents during MRI

Dramatically enhanced image contrast could revolutionize diagnostics and therapeutics

NIH $1 million Challenge Grant to refine cell-tracking nanotube technology

Covidien contraindicates use of its Optimark gadoversetamide injection

Discovery of AVM can relieve pain due to chronic back pain and neurologic deficits

St. Anthony Hospital installs Toshiba America Medical Systems' Vantage Titan MR system

Iodinated, Gadolinium based contrast agents do not negatively affect patients

Toshiba America Medical Systems installs its 800th Vantage 1.5T MR system

Hybrid metal and organic nanoparticles for targeting, imaging, and treating cancer

University of Nottingham back pain study wins prestigious research prize

Measuring nanoparticle behavior in the body using MRI

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News